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I. SUMMARY AND RECOMMENDATIONS
This study on the feasibility of manufacturing, purifying, isolating, or
separating biochemical and cellular materials in space has lead to the
following results:
1. There is little, if any, utility in processing pharmaceu-
ticals in space due to their generally relatively small
molecular size.
2. There is little confidence on the part of the industrial
and scientific community in this type of approach for
any application.
3. Nevertheless, there is a potential for the processing of
cellular materials under zero gravity conditions. The
only specific process suggested to us during the course
of the study was for the production of vaccines from
cellular material (Dr. Glick, President, Associated
Biomedical Systems). The same respondent also suggested
experiments on cell immortality in this context.
4. In general we attribute the negative and, at best,
apathetic response received to the fact that the pro-
fessionals involved take for granted that space processing
as well as experiments are not cost effective. In
addition, they probably have an understandable preference
for having presently limited government funding directed
to fields of direct interest to them. Thus, to arouse
their interest some plausible proof of potential cost
effectiveness would have to be clearly demonstrated to
them.
5. In view of this situation, we resorted to indirect
techniques for generating space process concepts, such
as Medlar searches, internal discussions, interviews,
and communications with scientists having even marginal
interest, etc.
6. Based on this, we generated a list of "Potential Bio-
chemical and Cellular Processes and Experiments" (Section
VI). Some of these had to be disqualified, but others may
lead to viable processes after further examination (see
recommendations below).
7. In view of the above it is not possible at this time to
come to definitive conclusions as to the practicability
of space processing of socio-economically useful products
in the classes examined.
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8. It appears, however, that the most promising areas for
further investigation are:
* Processes which are based on the use of cellular
materials which though the cells may not survive, may
produce useful products.
* Experiments with cellular materials to provide in-
formation vital to "on earth" research and processes.
In order to best utilize the above findings and to resolve the remaining
questions as to the practicability of space processing for the class of
materials under study we recommend that:
A. NASA enter into direct discussions with Associated Biomedic
Systems as to evaluation and possible implementation of
suggestions under 3 above.
B. When the T and B lymphocyte separation experiments in space
and/or the evaluation under A. above are successfully com-
pletedscientists in research and industrial organiza-
tions should be re-approached for discussion of suggestions
contained in the list of Section VI, as we believe such
a demonstration would create a better climate for unbiased
discussions.
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II. INTRODUCTION: METHODS AND RESULTS
A. PURPOSE OF THE STUDY
The National Aeronautics and Space Administration requested Arthur D.
Little, Inc., to study the feasbility of extracting, isolating, puri-
fying, separating, or preparing medical and biological products of high
socio-economic value in space. In particular, the study was designed to
concentrate on the isolation or purification of virals, pharmaceutical
and immunological agents by means of electrophoresis, as the Apollo 16
flight demonstrated that a mixed population of latex spheres (.2 and .8
microns) could be successfully separated by electrophoresis in space
and without sedimentation with minimal convection. This prompted NASA
scientists to look into the possibility of carrying out types of bio-
chemical experiments that would utilize space for medical purposes.
Our program did not deal, however, with the general biological experi-
ments that can be performed in space, but with the very specific problems
of producing useful materials in sufficient quantities for any given
biomedical application, and, if possible, of finding a potential manufacturer
for such materials.
Benefits to humanity must be established on the basis of social and
economic values and the competitive nature of the process when compared
with equivalent technology on earth. Furthermore, it implies, that if
a material is found to cure a given disease, this disease should have
socio-economic values beyond emotional considerations to justify performance
of the given material isolation.
B. METHODS
This program posed the very challenging problem of designing an approach
which was neither known nor predictable at the outset. Thus, not only
did we not know what substances we were looking for among pharmaceutical,
viral and immunological agents, but, in addition, it soon became evident
that space conditions were not per se competitive with existing earth
production procedures and, furthermore, there was little interest from
the potential commercial users of these techniques.
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Accordingly, we decided to take a multidimensional approach which would
give us some idea on how to identify possible materials, techniques and
users. Three main lines of approach were undertaken in parallel, as
discussed in the following.
1. Definition of Biophysical and Biochemical Properties That Are
Different in Space
The main object was to limit the set of possible materials that one
could possibly look at. We asked questions related to sedimentation times,
charge to mass ratios, etc., of various molecular and cellular entities
as well as the effect of gravity on various biophysical techniques. As
large gravitational fields are generally introduced on purpose in bio-
chemical and biophysical separations (such as ultracentrifuge work),
relevant problems required extensive thought and consultation. Our
conclusion was that only large biological particles, such as cells, or
functional cellular groups or tissues had potential isolation or purifica-
tion problems for which space could, at least in principle, provide an
answer. Smaller particles, including subcellular material, take extremely
long times to settle and thus offer little or no potential. Furthermore,
organized cellular structures can be separated on earth by microsurgical
dissection techniques, now well automated, while most cells of interest
cannot be kept viable for the long periods of time considered for the
program (including preshipment wait, flight time, return to appropriate
laboratories, etc.). In addition, freezing before return to earth for
storage would tend to destroy important functional properties of most
cells.*
This precludes in most instances the use of space processed viable cells
per se and thus we believe limits us to possible exploitation of products
produced by and from cells under space conditions and which do not lose
their activity by freezing or other return shipment requirements. In
addition, in experimental usage, return of information may be all that
is needed.
In terms of the biophysical techniques that are affected by gravity,
the other input to be considered, electrophoresis,was one of the two
found to have any relevance, as zero gravity eliminates problems of
convection and the requirement for a supporting material.
Another possible technique, more on the purely biological side, has to
do with cells that cannot grow when attached to glass and
might grow or reproduce indefinitely in space, just as cancerous cells
which do not exhibit contact inhibition.
Acceleration and deceleration should not affect cell viability as
cells survive normally accelerations in extremely large gravitational
fields in the ultracentrifuge for separation into various fractions.
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Our conclusions for this part of the study were:
* Only two techniques would show potential differences
in space: electrophoresis and cell culture in suspension.
* Only experiments with cells can be done.
* Only small molecules extracted from or information about the cells
themselves is worth returning, in the general case.
Some of the appropriate possible experiments are discussed in the section
on potential zero gravity processes and experiments. (Section VI)
During performance of this task we also studied competitive technology:
this includes an extremely fast cell sorting device made by Los Alamos
Scientific Laboratory and a dynamic gradient cell separator which, when
used in conjunction with a Ficoll gradient can separate T and B lymphocytes
on earth.
2. Users Requirements
A second technique consisted in approaching a significant sample of
pharmaceutical companies which manufacture macromoleculars, cellular
biochemicals, vaccines and immunologicals. These companies were chosen
by selecting those which manufacture macromoleculars listed in the
Physicians Desk Reference Book, and which, presumably, should have social
and economic value.
We found out, however, that most of these macromoleculars have no well-
determined use, many are placebos or digestive enzymes (Table 5 ). In
addition, as Table 6 shows, most of the bulk of pharmaceutical sales
come from tranquilizers, contraceptives, etc., and have little to do
with the types of substances that can be separated to advantage in space.
This indicates an immediate economic limitation in terms of the inertia to
be overcome by the pharmaceutical companies. While many responses were
obtained in response to our letters (Appendix 2 ) and our telephone calls,
no positive output was obtained from the companies, with the exception of
MERCK SHARP AND DORME which indicated that it is working on a system to
simulate zero gravity on earth by utilizing centrifugation and diffusion
across an equilibrium boundary. An additional important output was
obtained as a by-product from discussing this project with relevant
personnel at the companies, namely that little or no electrophoretic
equipment is used in production. Some is used, however, in research at
the pharmaceutical companies. This was puzzling as we had already found
out as a result of our literature searches that seven of the 70 most
cited journal articles for the period 1961-1972 were on the subject of
electrophoresis methodology (Table 8 ) and that the electrophoresis
equipment market is of the order of $22 million. Telephone contacts with
electrophoresis manufacturers confirmed that very little of their equip-
ment is sold to pharmaceutical companies; most equipment goes to
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academically-oriented research laboratories.
For this reason, we decided to contact research laboratories specifically
interested in electrophoresis and, in particular, cell electrophoresis.
The first step in the process was the literature search described below,
which served to generate specific research ideas and helped to identify
fields of work of various scientists. The response was good, but the
ideas submitted poor, nebulous or only expressing a willingness to
collaborate "if something happened." (See Appendix 4 ) Another approach
consisted in informally talking to various scientists at several research
and contractors conferences which included a meeting on mammalian cell
surface at Los Alamos Scientific Laboratory and a National Cancer Institute
contractors conference. The interest was marginal on the part of most
investigators, except for those which found the problem academically
intriguing.
3. MEDLAR Search
We requested the National Library of Medicine to perform a computer search
of the articles in various areas of techniques, macromolecular separations,
cellular electrophoresis, etc., for the years 1971-1973. Organized ref-
erences from this study are given in Appendix 3 . We selected specific
articles for introductory discussion and looked in detail at those which
seem to warrant further attention. We then contacted the scientists who
had written the given article, as described above in 2. The various
substances and techniques we looked into are given alphabetically in
Appendix 4 .
4. Internal Generation of Ideas
Because of the poor external response to the NASA program, we decided to
generate internal ideas at Arthur D. Little, Inc., and are providing those
in Section V. Again, we exposed many scientists to these and their usual
reaction was a "wait and see" response; they would like to see the
experiments performed, but nobody wants to endorse them directly. The
importance attached to these experiments is, at present, hard to assess;
multiple layers of screening and evaluation will certainly have to pre-
cede experiments of the order of cost envisaged and, before this is done,
it seems practically impossible to obtain relevant, unbiased judgment from
peer scientists. Part of the problem may be naturally solved once the
experiments proposed on T and B lymphocytes, lipoproteins, etc., are run
and the scientific community can judge directly the merits of this type
of space experimentation.
5. Clinical Tests
We have also analysed the area of common clinical tests (see Appendix 6)
to determine what types of improvement are required. Suggestions for
space tests have been included with the research suggestions.
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III, BIOPHYSICAL CHARACTERISTICS REQUIRED OF
CANDIDATE COMPOUNDS AND TECHNIQUES
A. INTRODUCTION
In conjunction with the active search for appropriate candidate materials
that could have potential use to humanity--performed by contacting various
pharmaceutical companies, instrument manufacturers, scientists, etc.--we
carried out an analysis of the characteristics that any candidate compound
should have in order to be advantageously separated and purified as com-
pared to other materials in space.
The following questions had to be answered in order (see Flow Chart 1,
for appropriate outputs):
* What are the physical characteristics of space that makes it
different from the earth laboratory from the biological, bio-
chemical, biophysical or physical points of view, i.e., what
does a molecule, cell, virus, etc., "see" in space that is
different from earth?
* Given the above, which are the substances, biological
materials, etc., that could be considered potential
candidates?
* What techniques are used on earth to isolate the potential
candidates?
* How does space affect the isolation, purification, or
fractionation technique itself?
* Can the candidates be put in orbit and brought back to
earth without deterioration of the material?
* Is the experiment actually representing a unique zero
g situation or can the same factors be reproduced on earth?
Some of these questions are described below, not in reference to specific
materials,but in terms of the general requirements of the experiment.
B. SPECIFIC FACTORS
1. Physical Characteristics of Biological Entities
Any molecule, virus or cell has associated with it a size, shape,
weight, and certain surface characteristics such as attached charges,
special receptors and reactive groups. In addition the structure should
7
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FLOW CHART 1
INFLUENCE OF SPACE ON MATERIAL
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be considered as an open system which can interact with the environment
through exchange of energy and in the case of cells, through exchange of
small molecules which move actively or passively through the cell membrane.
The only relevant effects of space are: (a) the lack of weight in space,
(b) the biochemical effects of high radiation levels when unshielded
(such as mutations, etc.) and (c) the possibility of cell growth not
limited by contact inhibition with other cells or container vessels.
2. Effects of Space on Biophysical Techniques for the Study of
Molecules, Cells and Viruses
a. Techniques to study size: Chromatography and membrane
transport processes are not affected by gravity.
b. Techniques to detect shape: This may involve microscopes
as detecting devices (either manually operated or automatic)
X-rays and electron sources. No important effects of
gravity are present.
c. Density Techniques: Equilibrium or dynamic sedimentations
ranging from lg to ultracentrifuge fields clearly depend
on gravity for achieving sedimentation, separation, etc.
Sedimentation, centrifugation and ultracentrifugation all depend on the
relative velocity and equilibrium distribution of materials of different
density under the action of a potential energy gradient; particles are
separated from solution forcing them into separate compartments of the
fluid under the influence of this gradient.
In a gravitational field particles in a fluid settle at a velocity
given by Stokes' Law:
V 2 r ( - po) (1)9 n
Where: V is the terminal settling velocity
p is the density of the particle
po is the density of the solvent
n is the viscosity of the solvent
r is the particle radius, and
g is the strength of the gravitational field.
It is evident from Equation (1) that large particles settle rather rapidly
under a gravitational field, while small particles settle extremely
slowly. (A 0.1 micron particle of density 1.1 settles in water under
earth gravity at only 8 x 104 cm/hr.) Red cells in blood settle only
a few centimeters per hour. Thus, normal sedimentation is effective
only for the separation of fairly large particles.
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Centrifugation provides a means of increasing the apparent gravitational
field by as much as 25,000 times. Thus, small particles such as blood
cells can be efficiently separated within reasonable times. Ultracentri-
fugation extends the ordinary centrifugation process by operating at much
higher speeds. This allows separation of very small particles (e.g.,
viruses) and even allows separation by fractionation of large dissolved
molecules (such as blood proteins). Suspending solutions of varying
fluid densities are frequently used to maintain the molecular solutions
in discrete layers -(i.e., to prevent remixing of the separated molecules).
Sucrose solutions are frequently used to produce these solution gradients.
Natural sedimentation is impossible in a zero gravity environment, since
it depends on the force of gravity to produce the action. Centrifugation
and ultracentrifugation would be relatively unaffected by a zero gravity
environment since the induced acceleration forces are large compared to
the force of earth gravity.
3. Effects of Gravity on Techniques for Measurin g.Surface Properties
Clearly, techniques based on specific attachment or adsorption are not
affected by gravity. Electrophoresis, one of the most important techni-
ques for surface property measurements, is affected by gravity in two
ways when fluid electrophoresis is performed without a supporting medium:
(a) large particles sediment as they move in the electrophoresis tube,
and (b) the boundaries of the vessel and center have different temperatures
because of Joule heating; as the hotter part of the solution is lighter
and the colder part sinks, convection and mixing results. This can be
reduced on earth by working at a temperature close to that of maximum
solvent density (40C for aqueous solutions). The change of liquid density
with temperature is small or negligible at that temperature and convection
minimal. (In the case of electrophoresis on a supporting medium, however,
the heat effects change the net particle mobility but there is no convec-
tion.) Convection effects can be minimized by utilizing narrow electro-
phoresis tubes. The lack of convection and sedimentation in space
electrophoresis was clearly demonstrated by the separation of two
populations of latex spheres which had been mixed, although there were
electrostatic effects which prevented complete particle separation.
4. Materials and Techniques of Choice
The most relevant situation in space consists of running experiments in
a fluid electrophoresis cell of a biological particle that would normally
sediment on earth during the times of the experiment. Typical biological
units are listed on Table 1 and sedimentation rates on Table 2. Clearly,
for taking into account the amount of time needed for any of the units
considered in a typical purification or isolation experiment, only
cellular space separation and tissues or organized cellular structures
are worth considering.
10
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TABLE 1
ISOLATION OF CELLULAR ELEMENTS
BIOLOGICAL UNIT SEPARATION TECHNIQUE PRESENT PROBLEMS
* Marcomolecules Centrifugation Separation of
(Proteins, D.N. A., R. N. A.) Chromatography acidic nuclear
proteins
* Organelles Centrifugation Isolation of
- Nuclei mitotic spindles
- Mitochondria (microtubules)
granules containing
- Lysosomes (De Duve, 1963) 
Duve,1963)specific enzymes
- Glycogen granules specific enzymes
(Greene, Hirsand, Palade, or transmitters
1963)
- Histamine granules (Hagan,
Barrnett and Lee, 1959)
- Catecholamine granules
(Blascko, 1959)
- Vasopressin granules
- Oxytocin granules
(Weinstein, Malamed,
Sachs, 1961; Barer et.
al., 1963)
- insulin granules
(Lindall et. al., 1963)
* Viruses Chromatography See purification
Electrophoresis required,
Appendix 7
" Suborganelles
- Nucleoli (Maggio et.
al., 1963)
- Electron transport chain
fragments (Lusena and
Dass, 1963)
" Whole Single Cells Sedimentation See text
Centrifugation
" Organized Cellular Structures Disection, etc.
(tissues)
- Renal Glomemlae (Cook;
Pickering, 1969)
- Separation of sperm heads
and tails (Masaki & Hartree, 1962)
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TABLE 2
SETTLING RATE OF PARTICLES
Settling
Rate in
Sed Water in Distance
Density Molecular Mean Radius Coeff 1G Field Settled in
Particle gm/cc Weight x cm/sec dyne cm/sec 1 Hour
Ribonuclease 1.37 12,400 16.8 1.6 x 10- 13 1.6 x 10-10 5.6 x 10- 7
Serum Albumin 1.36 66,000 29.5 4.31 x 10- 13 4.2 x 10-10 1.5 x 10- 6
Tobacco mosaic
virus 1.37 50,000,000 268 170 x 10 1 3  1.7 x 10 6.0 x 10
Human lymphocytes 1.072 10p 2 x 10- 4  about 1 cm
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Cell surface groups that contribute to variations in charge mobility are
studied indirectly by treating the cell surface with enzymes which
specifically remove groups from the surface. Common groups which contrib-
ute to the electrokinetic charge are (see J.N. Mehrishi and A.E.R. Thomson,
(1968) Nature 219, 1080.) given in Table 3.
TABLE 3 SOME OF THE GROUPS WHICH CONTRIBUTE TO CELL CHARGE
GROUP SUSCEPTIBILITY TO CELLS REFERENCE
(enzyme)
a-carboxyl of Neuraminidase Erythrocytes Piper, 1957
NANA (N-acetyl- Cook, et al, 1961
neuraminic acid) Eylar et al, 1962
Blood Platelets Madoff, et al,
Lymphocytes Mehrishi, 1968
Leukocytes Vassar, et al, 1969
Phosphate Groups Ribonuclease Lymphocytes Mayhew and Weiss, 1968
Tumor Cells Mayhew and Weiss, 1968
Phosphate Groups Alkaline Blood Platelets Mehrishi, 1970b
Phosphatase
Small molecules, macromolecules, viruses, organelles and suborganelles
fall too slowly under the action of gravity.
Organized cellular structures, however, may be separated on earth by
microdissection. Cells, on the other hand, will be extremely hard to
keep viable after all transfers and waiting periods required for space
shipment. Furthermore, functional properties in most cases will not
survive freezing. Critical cell types, such as bone marrow, cannot
survive for more than a few days, even if strict environmental conditions
are met.
This leaves two options in terms of material return:
* small molecules produced by the cells, or
* information on experiments performed on cells (this could
13
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include observations performed aboard as well as bringing
back the nonfunctional dead cell to earth).
A third possibility, which was not originally required from our program,
but may be useful, consists in running model systems (such as quartz
spheres containing mosaics of charged groups similar to the charge
groups present on cell surfaces).
14
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IV. APPROACHES BASED ON USERS AND NEEDS
This task had the following objectives: (a) obtain suggested experiments
and candidate materials from the pharmaceutical, research, and clinical
groups, and (b) utilize these groups as a feedback system to check our
own selected -deas.
In order to contact appropriate pharmaceutical companies on some rational
basis, we assembled the list of macromolecules shown in Table 4, and
contacted manufacturers of these. This list comprises all the macro-
molecules with known therapeutic value and are included in the Physicians
Desk Reference. At that time, we had not decided to concentrate on
cellular material and we hoped to find a pharmaceutical process with
potential economic and social value which could take advantage of space
extraction or purification. The exercise was instructive in itself.
First, we found out that most of these materials do not have a great
social value, as shown in Table 5 which describes the present sources
and applications of these materials. Second, these materials have little
economic value and do not comprise the bulk or even an important part
of the pharmaceutical industry dollar output. (See Table 6 for types
of products with high sales.)
The manufacturers were contacted by letter and by telephone. In those
cases where letters were not answered, a follow up was required. Responses
were generally negative as shown in Summary Table 7. Response letters
are presented in Appendix 2.
A very surprising finding of this part of the study was that there seemed
to be no use of electrophoresis equipment in pharmaceutical production
processes. We checked this fact with some of the leading manufacturers
of electrophoresis equipment to find out who buys this type of instru-
mentation (the market is estimated to be $22 million) and found out that
most equipment is sold to research scientists.
While, as stated, electrophoresis is hardly used in industrial processes,
the biological research area is dramatically more fertile. Electro-
phoresis is an important and commonly used tool in contemporary basic
research. A recent study by the Institute for Scientific Information
(Garfield, E., Current Contents, January 9, 1974, and Garfield, E.,
Current Contents, February 6, 1974) reveals that seven of the 70 most-
cited journal articles for the period 1961-1972 are on the subject of
electrophoresis methodology. These articles are listed in Table 8.
16
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TABLE 4
LIST OF MACROMOLECULES WITH KNOWN THERAPEUTIC VALUE
WHICH ARE INCLUDED IN THlE PHYSICIANS DESK REFERENCE
Allergens Enzymes (Fibrinolytic)
Antigens Fibrinogen (Human), U.S.P.
Anti-Serum Glucagon for Injection U.S.P.
Immunosuppresive Heparin Preparations
Plasma Fractions Insulin
Serum Intrinsic Factor Concentrate
Toxoids Lipolytic Enzyme
Adrenocorticotropic Hormone Papain
Albumin, Normal Serum Pepsin
Alginic Acid Secretin
Amylolytic Enzyme Sodium Nucleate
Anterior Pituitary Hormones Streptokinase-Streptodornase
Bromelains Thyroglobulin
Cellulase Trypsin
Chondroitin Sulfate
Chorionic Gonadotropin
Chymotrypsin
Collagenase
Desoxyribonuclease
Enzymes (Debridement)
Enzymes (Digestant)
17
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TABLE 5
USES OF REPRESENTATIVE MACROMOLECULARS LISTED IN THE PHYSICIAN'S DESK REFERENCE
Name Use Main Chemical Components Source
* Adenocorticotropic Rheumatoid disorders Corticotropin U.S.P. Anterior petuitary hormone
Hormone Acthar (Armour) Collagen diseases Gelatin
Dermatologic diseases Phenol
Allergic states
Ophthalmic diseases
Respiratory diseases
Hematologic disorders
Neoplastic diseases
Edematous state
* Albumen, normal serum
Albuspan (Park Davis) Shock Serum albumin isotonic Venous and/or placental plasma
Albuminar (Armour) Hypoproteinemia iso-osmotic with pooled
Alburnin (Cutter) Hyperbelerubinemia and whole human plasma
erythroblastosis fetalis
* Alginis Acid
Marion Temporary relief of Alginic acid 200 mg When chewed produce a viscous
Pepsin heartburn caused by Aluminum hydroide demulcent antiacid foam which
Lipolytic reflux of contents from Sued gel 80 mg coats
stomach Sodium bicrabonate 70 mg
* Amylolytic enzyme
Medical products Flatulence, nervous Lipase
paramericana indigestion, gastric Amylase
Hoechst idstress, intestinal Protease
Geriatric hypermotility and spastic Bile salts
Warren-Teed colon
Kremers-Urban
Ulmer
Rowell
18
TABLE 5 (Continued)
Name Use Main Chemical Components Source
* Anterior Pituitary Rheumatic disorders Corticotropin Anterior pituitary hormoneHormones Collagen diseases
Armour Dermatologic diseases
Allergic states
Ophthalmic diseases
Respiratory diseases
Hematologic disorders
Neoplastic diseases
Edematous state
* Bromelains
Rorer Supplement and augment Concentrate of proteolytic Pineapple plant
standard therapeutic enzymes
procedures for reduction
of inflammation and
edema to ease pain,
speed healing and
accelerate tissue repair
* Cellulase
Wampole Reduces flatulence, Cellulase, amylase, Aspergillus niger (cellulase)
Dorsey relieving constipation, protease, lipase
Ulmer improving appetite or
Hoechst digestion from eating
Geriatric vegetables with high
Kremers-Urban cellulose content--
cucumbers, lettuce, etc.
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TABLE 5 (Continued -3-)
Name Use Main Chemical Components Source
e Chondroitin sulfate
Marcen Prevention and treatment Pancreas extract Acid-alcohol treated pancreas
of atherosclerosis (epinephrine--neutralizing
Useful adjuncts Pancreas extract 80% alcohol extractive of depro-
- Angina pectoris (lipotropic fraction) teinated pancreas
- Peripheral vascular
diseases
- Intermittent claudication
- Reduces blood
cholesterol and lipo-
protein levels
* Chorionic gonadotropin
Ayerst Given in an attempt to Human chorionic
Research supplies stimulate the interstitial gonadotropin (APL)
cells of the testes to
produce androgen
- Delayed adolescence
- Hypogonadotropic
eunuchoidism
* Chymotrypsin
Armour Indicated for enzymatic Chymotrypsin Proteolytic enzyme
Wampole zonulysis for intra-
Warren-Teed capsular lens extraction.
Merrell-National Dissolves zonular fiber
attached to the lens by
proteolytic enzymatic
action. As anti-inflammatory
action in cases of urologic
surgery, episiotomy, surgery
of head and neck.
e CollagenaseAdvance Biofactures Debriding dermal ulcers Collagenase activity Fermentation of clostridium
Knoll and severely burned 
histolyticum
areas 20
TABLE 5 (Continued -4-)
Na.e Use Main Chemical Components Source
" Desoxyribonoclease Debriding agent for Fibrinolysin From two lytic enzymes:
Parke, Davis inflammatory and inffected Desoxyribonuclease Fibrinolysin: bovine enzyme
lesions: Desoxyribonuclease: isolated
general surgical wounds in a purified form from
ulcerative lesons-tropic bovine pancrease
decubitus, stasis,
arterioslerotic
second and third degree
burns
circumcision and
episiotomy
irrigating agent in:
infected wounds-abscesses
fistulae, and sinus tracts
otorhinolaryngologic wounds
superficial hematomas
* Enzymes (Debridement)
Armour Digest necrotic tissues Neomycin palmitate From mammalian pancreas glands
Parke, Davis pyogenic membranes and Trypsin-chymotrypsin
Rystan crusts to cleanse wounds and
Flint remove foul odors
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TABLE 5 (Continued -5-)
Name Use Main Chemical Components Source
* Enzymes (Digestant)
Lakeside Disorders of motility of Mepenzolate bromide or
Warren-Teed the lower gastrointestinal phenobarbital
Kremers-Urban tract:
Nutrition Control irritable colon
VioBin colitis, mild chronic
Brunswick ulcerative
Standard Process rectospasm
acute enterocolitis
diverticulitis
* Enzymes (Proteolytic)
Warner-Chilcott Reduction of edema Proteolytic enzyme Caraca papaya
* Fibrinogen (human)
U.S.P.
Cutter No information No information No information
* Glucagon for Injection
U.S.P.
Lilly Counteracts severe Straight chain polypeptide Produced in the pancreas
hypoglycermic reactions containing twenty-nine (alpha cells of the island
in diabetic patients-- amino acid residues of langerhans)
or during insulin shock
therapy in psychiatric
patients
* Heparin Preparations
Upjohn Inhibits the coagulation Sodium heparin Intestinal mucosa
Abbott of blood and the formation
Riker of fibrin clots both in
vitro and in vivo
* Insulin
Squibb Keeps sugar content Antidiabetic principle of
Burroughs Wellcome at a balance beef pancreas or pork pancreas
Lilly
TABLE 5 (Continued 
-6-)
Name Use Main Chemical Components Source
* Intrisic factor
concentrate
Breon Relief of bronchospasm Ethylnorepinephrine Synthetic sympathomimetic
Upjohn in bronchial asthma amine
Lederle
Lilly
* Papain
Boyle Antihistaminic Phenylephrine
Rystan Decongestant, analgesic for HCI
relief of nasal conjectant Pheniramine maleate
muscular aches and pains Salicylamide
and common pollen allergies Phenacetin
* Secretin
Warren-Teed Diagnosis of pancreatic Secretin-Boots Hormone, porcine duodenal
disorders mucosa
freeze dried, refined
* Sodium nucleate
Marcen When leukopenia occurs in Sodium nucleate
certain pyogenic diseases
normally accompanied by
leukocytosis, Vero-
Zyme may be used as an
adjunct to suitable anti-
biotic therapy to promote
leukocytoses and phagocytosis
* Streptokinase-
streptodornase
Lederle Treatment of edema Streptokinase Strain of streptoccus
associated with infection Streptodornase
and trauma
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TABLE 6
ESTIMATED MONTHLY CONSUMER SALES OF SELECTED ETHICAL
PHARMACEUTICAL PRODUCTS'
(Mfrs. sales dollars)
Estimated Domestic Sales (MS)
. 1973
Therapeutic 1973
Product Manufacturer Class June July August September
Loestrin Group Parke, Davis & Co. progestogen 25 40 50 75
(Warner-Lambert Co.)
Nor-Q.D. Syntex Corp. progestogen 40 40 50 40
Micronor Ortho Pharmaceutical progestogen 30 30 25 20
(Johnson & Johnson)
Darvon-N Group Eli Lilly& Co. analgesic 900 1,050 1,000 900
Darvocet-N Eli Lilly & Co. analgesic 450 500 625 675
Dolene 65 Group Lederle Laboratories analgesic 20 30 25 25
(American Cyanamid Co.)
SK-65 Group Smith Kline & French analgesic 90 80 90 75
Laboratories
(SmithKline Corp.)
Sinequan Pfizer Laboratories tranquilizer, 1,300 1,800 1,800 1,900
(Pfizer, Inc.) antidepressant
Adapin Pennwalt Pharmaceutical tranquilizer 75 85 85 110
Products
(Pennwalt Corp.)
Tranxene Abbott Laboratories tranquilizer 450 650 700 700
Promapar Parke, Davis & Co. tranquilizer 25 20 20 20
(Warner-Lambert Co.)
Chlor-PZ USV Pharmaceutical Corp. tranquilizer 25 20 20 20
(Revlon, Inc.)
Tofranil PM2  Geigy Pharmaceuticals psychostimulant - - - 20
(Ciba-Geigy Corporation)
Aarane Syntex Corp. bronchodilator 25 150 200 225
Intal Fisons Corp. bronchodilator - 200 150 100
Alupent 2  Boehringer Ingelheim Ltd. bronchodilator - - - 20
Sanorex SandozPharmaceuticals antiobesity - 170 375 325
(Sandoz-Wander, Inc.)
Pondimin A.H. Robins Co. antiobesity - 60 200 175
Voranil USV Pharmaceutical Corp. antiobesity - 90 125 100
(Revlon, Inc.)
Principen/Probenecid E. R. Squibb & Sons antibiotic - - 100 75
(Squibb Corp.)
Polycillin PRB Bristol Laboratories antibiotic - - 60 60
(Bristol-Myers Co.)
Septra Burroughs Wellcome & Co. antibacterial - - 125 400
(Wellcome Foundation Ltd.)
Bactrim Roche Laboratories antibacterial - - 250 300
(Hoffmann-La Roche, Inc.)
1. Monthly estimates are based on product sales to consumers and exclude sales far inventory purposes.
2. New product.
Source: Arthur D. Little, Inc.
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TABLE 7 RESPONSE FROMMANUFACTURERS
COMMUNICATION
COMPANY *LETTER VERBAL DATE OF RESPONSE SUMMARY OF RESPONSE
Abbott + - 11/1/73 Grant H. Barlow is working with Marshall Space Flight
Center now on a possible experiment for the Soyez-
Apollo Flight in 1975. Would like to discuss with us.
American Cyanamid, + - 11/30/73 Mr. Ringler, Director of Research is unable to sug-
Lederle Labs gest any appropriate experimentation.
American Hospital + - -
Supply
Wyeth (Am. Home + - -
Products)
Armour Pharmacue- + - 10/25/73 Armour has no interest at present but will send a
tical Co. copy to Professor Craig Wall at Baylor College
of Medicine, Texas Medical Center.
Ayerst, Div. Am. + - 10/19/73 Copies of the letter forwarded to the administrators
Home Products of the Research and Development Department.
Baxter - + 10/15/73
Becton-Dickinson - + 10/16/73
Brunswick Labs. + - - -
Cutter Labs. + - - -
Difco Labs., Inc. + - - -
Dome-Miles Lab., Inc + - - -
Dorsey Labs. + - -
*all letters were mailed on 10/17/73 25
TABLE 7 (continued)
COMMUNICATION
COMPANY LETTER VERBAL DATE OF RESPONSE SUMMARY OF RESPONSE
Dow Pharmaceuticals + - 11/27/73 At the present time they do not have a project which
would qualify for the program.
Flint-Div. of + -
Travenol (Baxter)
Hoechst Pharmaceutical + -
Co.
Hollister-Stier + - 11/15/73 Company sent a folio containing literature and infor-
mation on different products manufactured by the
company for the diagnosis and treatment of the
allergic patient, also instruction sheets which
accompany the various extracts. Interest in helping
to devise a TINE system.
Johnson & Johnson + - 10/25/73 No contribution to the project.
Orthodiagnostic Div.
Kremers-Urban + -
Eli Lilly Co. + -
Marion Labs. + - 10/24/73 Company is not involved in this area and most likely
will not be in the immediate future.
Merck Sharp & Dohme + - 10/22/73 At present they are not able to suggest a substance
1/15/74 which would be best isolated using electrophoresis
> under zero-gravity conditions. Two other areas of
potential interest for an experiment is space: the
rapid and profound demineralization, the examination
of the circadian rhythm (space agency has done work
rin rat area).
all letters were mailed on 0/17/73 26
*all letters were mailed on 10/17/73 2
TABLE 7 (continued)
COMMUNICATION
COMPANY *LETTER VERBAL DATE OF RESPONSE SUMMARY OF RESPONSE
Organon, + -
Diagnostics Div.
Pfizer Labs. - + 10/15/73 No interest--Biochemist on staff was approached by
NASA-staff prior.
Philips Roxane - -
Richardson-Merrell, + - 10/26/73 Staff will review letter and respond if indicated.
Inc.
W. H. Rorer, Inc. + -
Schering Corp. + -
Schering Diagnostic
Squibb + -
Smith, Kline & French + -
Warner Lambett + - -
Pharmaceutical Co.
Warren-Teed + - 10/25/73 Sam Gusman has forwarded a copy of the letter to
(Rohm & Haas) associates at the Rohm and Haas Co. If there is
interest they will get in contact
11/7/73
Upjohn Co. - + 10/15/73 No interest
*all letters were mailed on 10/17/73
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TABLE 8
POPULAR ELECTROPHORESIS ARTICLES
RANK TIMES CITED BIBLIOGRAPHICAL DATA
11 3464 Davis, B. J. Disc electrophoresis. 2. Method
and application to human serum proteins. Ann.
New York Acad. Sci. 121:404-27, 1964.
13 2903 Scheidegger, J. J. Une micro-methode de l'immuno-
electrophorese. Internat. Arch. Allergy 7:
103-10, 1955.
26 1841 Smithies, 0. Zone electrophoresis in starch
gels: group variations in the serum proteins
of normal human adults. Biochem. J. 61:629-41,
1955.
42 1297 Ornstein, L. Disc electrophoresis. 1. Back-
ground and theory. Ann. New York Acad. Sci.
121:321-49, 1964.
51 1204 Smithies, 0. An improved procedure for starch-
gel electrophoresis: further variations in the
serum proteins of normal individuals. Biochem.
J. 71:585-57, 1959.
63 1066 Poulik, M. D. Starch gel electrophoresis in
a discontinuous system of buffers. Nature 180:
1477-79, 1957.
69 1023 Shapiro, A. L., Vinuela, E. and Maizel, J.V., Jr.
Molecular weight estimation of polypeptide chains
by electrophoresis in SDS-polyacrylamide gels.
Biochem. Biophys. Res. Comm. 28:815-20, 1967.
A similar poll of instrument usage by American Laboratory readers shows
that nineteen percent of the 2,000 respondents in this survey used
electrophoresis equipment. This figure has remained constant over the
years around twenty percent usage. The significant fact here is that
only eight percent expected electrophoresis to make the greatest contribu-
tion in the respondent's field in the next three years. Other facts
coming out are that university chemists use electrophoresis equipment
significantly more than industrial chemists, and the same is true for
university biologists.
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Thus, we decided to contact research scientists at leading universities.
A Medlar search from the National Library of Medicine was started covering
various areas of cell, macromolecular separation, clinical tests, etc.
Appendix 3 gives the series of references, organized according to the
type of laboratory work they represent (clinical, special techniques, etc.).
We selected specific references after all abstracts were scanned for
possible interest. An alphabetical listing of the biological materials
and special techniques included is given in Appendix 4.
Once experiments which could have potential space remifications were
detected we contacted individual scientists who had written the specific
articles. The reply letters are given in Appendix 5. An alternate
approach was taken by discussing various types of experiments with
scientists we met at scientific meetings, including a conference on
mammalian cell surfaces (held at Los Alamos Scientific Laboratory) and
a National Cancer Institute contractors conference. Most of the responses
were either negative or lacked substance. Some of the reluctance on the
part of scientists to consider this type of experimentation may be caused
by unfamiliarity with the field. If the experiments proposed by NASA on
T and B lvmphocytes and lipoproteins can be demonstrated to work in space,
we would expect many scientists will feel more confident with this program.
A very positive output was obtained from Dr. Leslie Glick, President of
Associate Biological Systems, a company which produces large quantities
of human cells in culture for specific genetic purposes. Dr. Glick
suggested two types of experiments (mentioned in the experiments section):
(a) utilization of space cell culture to test the immortality of normal
cell lines in the absence of contact inhibition, and (b) utilize the
zero g capabilities for attaching cells to floating spheres thus providing
a large attachment area; cells which produce vaccines could generate
extremely large amounts of material this way as it is not feasible to
grow them in monolayers in large areas on earth. Dr. Glick is interested
in collaborating with NASA and he sees very positive potential economic
applications for the program.
We also evaluated the potential use of space procedures in clinical
testing. The most common clinical tests were reviewed (Appendix 6) and
some of the needs, which may or may not be met by space, are given in
the experiments section. Appendix 6 gives a list of government classified
viruses that need further purification.
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V. COMPETING TECHNIQUES ON EARTH
In order to consider the possible technical advantage of processing in
space, it is also necessary to consider the competing technology and
instrumentation on earth. We only include the most relevant procedures,
excluding detailed advances in electrophoresis such as precast gels or
isoelectric focusing techniques, which we have documented through the
extensive bibliography given at the end of the report.
A. MICROSCOPE CELL ELECTROPHORESIS
The apparatus designed by Mehrishi (British Patent No. 2782/71) is extremely
inexpensive and can separate populations of cells with computer printout
and mobility distributions in short experiments running 10-20
minutes. In this system a very narrow tube is utilized (2 - 2.4 mm)
so that no problems of heat convection appear. Mobilities are measured
by means of a microscopic system which is focused a distance .293 R from
the inner radium of the wall of a tube of radium R. At this point the
electro-.osmitic effect is zero and the true mobility of the cells is
determined. The maximum sensitivity of the system is 5 x 105 to 1 0 6
ionic groups, mobility changes cannot be determined in heterogeneous cell
populations. A change in 10% mobility for a human erythrocyte, for
example, (mobility 1.08 microns/sec/V/cm) corresponds to the removal of
only 6 x 10-16 gms of NANA (N-acetyl neuraminic acid, responsible for
the charges on the surface) from the erythrocyte surface. Although this
method is not subject to convection and electro-osmosis , it has the dis-
advantage, compared to space electrophoresis, that it can only deal with
small samples in short times. The space electrophoresis system has the
advantage of the long-time capabilities which allow for better separation
with the same field strength.
B. FORCED FLOW ELECTROPHORESIS AND ELECTRODECANTATION
These two techniques are aimed at obtaining large fractions of materials
with little generation of heat. In electrodecantation, which has been
used to prepare immunoglobulin fractions from hyperimmunized plasma,
macromolecules are separated on the basis of their size (through the
introduction of two semipermeable membranes between the electrodes),
sedimentation and mobility properties--as shown in Figure 1.
Forced flow electrophoresis seems to have great potential for fractiona-
tion of proteins on a large scale. In this process both electrodecantation
and bulk flow is utilized for the fractionation, as shown in Figure 3.
The system has been applied to whole plasma for the removal of IgG anti-
body and it has been automated with controls for temperature, pH, etc.,
to run for long periods handling volumes of protein solution of 1,000
liters per week.
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C. DYNAMIC SEDIMENTATION AT 1ig
In this system, Figure 4, cells are forced to layer into a narrow band
at the same time that a sucrose or other gradient is set in the vessel.
After one to two hours of sedimentation, the cells are extracted by
forcing them to coalesce into fractions through a very clever inverted
funnel system. Cells never reach their equilibrium sedimentation point
so that this constitutes a dynamic system. This device is presently
utilized to attempt isolation of cells in the Go stage of the cycle.
Although the gradients utilized do not allow separation of T and B
lymphocytes at present, it can obtain extremely pure T and B fractions
when utilized in conjunction with a Ficoll gradient (personal communica-
tion, Dr. R. Barr, National Cancer Institute).
D. CELL SEPARATION BY SELECTIVE ATTACHMENT TO SPECIFIC MATERIALS
Very effective concentrations of viable granulocytes can be obtained by
the leukopack, which is a simple sausage containing nylon fibers through
which whole blood is passed for transfusion purposes. The granulocytes
attach to the nylon fibers in high concentration after several passages
of the donor's blood through the system and cells can then be simply
extracted with saline. These cells are used for transfusions to leukemic
patients.
E. LOS ALAMOS CELL SORTER
A very promising instrument which may find many applications in the coming
years is the LASL sorter. This is an instrument which separates single
cells into three fractions according to their fluorescence. The fluorescence
excitation system is an Argon laser and cells are carried through the air
in a drop of saline which gets charged on the basis of the amount of
fluorescence in the cell, then deflected by a system similar to a T.V.
deflection system. Although the system can now sort cells into only
three fractions, it can easily be adapted to classify cells in as many
as two fractions on the basis of both size and fluorescence. Large
numbers and concentrations of cells can be separated as this instrument
handles several thousand cells per minute.
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. POTENTIAL BIOCHEMICAL AND CELLULAR SPACE
PROCESSING AND EXPERIMENTS
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A. PROCESSING
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PRODUCE LARGE AMOUNTS OF VIRAL VACCINES
DESCRIPTION: CELLS WHICH GROW IN MONOLAYERS IN CULTURE ARE HARD TO
OBTAIN IN LARGE QUANTITIES ON EARTH. BY FLOATING SMALL
MICROSPHERES IN THE ABSENCE OF GRAVITY VERY LARGE SURFACE
TO VOLUME COULD BE OBTAINED AND CELLS WOULD GROW IN
MONOLAYERS IN LARGE QUANTITIES, THUS PRODUCING LARGE
AMOUNTS OF THE VACCINE. ELECTROENDOSMOSIS COULD INCREASE
THE TRANSPORT OF NUTRIENTS AND WASTES THROUGH THE CELL
MASS.
PURPOSE: PRODUCE LARGE AMOUNTS OF VIRAL VACCINES BY CELLS WHICH
GROW IN MONOLAYERS.
BACKGROUND: EXPERIMENT PROPOSED BY DR. LESLEY GLICK, PRESIDENT OF
ASSOCIATE BIOMEDIC SYSTEMS.
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PRODUCTION OF EFFECTIVE CANCER ANTIBODIES
PURPOSE: ISOLATE CELLS CAPABLE OF ELICITING EFFECTIVE ANTIBODY
PRODUCT I ON.
PROCEDURE: SEPARATE TRYPSINIZED TUMOR CELLS BY ELECTROPHORESIS.
PRODUCE ANTIBODIES USING CELLS FROM VARIOUS FRACTIONS,
THEN CHECK FOR MOST EFFECTIVE FRACTION (THE ANTIBODY
WILL BE HIGHLY CONCENTRATED IN THIS ONE).
ADVANTAGE: BETTER CELL FRACTIONATION IN SPACE.
37
Arthur D Little Inc
POLLEN ELECTROPHORESIS
PURPOSE: ISOLATE POLLENS, TO OBTAIN MORE PURIFIED ALLERGEN FOR
BOTH DIAGNOSIS AND TREATMENT.
ADVANTAGES NO PRECIPITATION, SENSITIVE SEPARATION OF SLIGHT CHARGE
OF SPACE: DIFFERENCES AND MASS.
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PURIFICATION OF ANTISERA
PURPOSE: PURIFY SPECIFIC ANTISERA TO PERFORM RAPID TESTS FOR A2
AND FETAL HEMOGLOBINS, ALKALOIDS, AND LIPOPROTEINS.
DISCONTINUE: NO ADVANTAGE OF SPACE PURIFICATION FOR MACROMOLECULES.
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ISOLATE CHROMOSOME FRACTIONS
PURPOSE: BEYOND THE RESEARCH INTEREST THE AVAILABILITY OF SPECIFIC
PURIFIED HUMAN CHROMOSOMES WOULD ALLOW DEVELOPMENT OF
SPECIFIC FLUORESCENT ANTIBODIES TO THE CHROMOSOMES, SO
THAT A RAPID METHOD WOULD BE AVAILABLE FOR DOING CHROMOSOME
ANALYSIS ON EARTH.
ADVANTAGE OF CHROMOSOME SEPARATION TECHNIQUES ON EARTH DO NOT GIVE
SPACE: PURE CHROMOSOME FRACTIONS, THERE IS CLUMPING AND PRECIPI-
TATION; SPACE ELECTROPHORESIS PURIFICATION WOULD AVOID
PRECIPITATION.
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PURIFICATION OF ANTIBODIES
PURPOSE: IMPROVE PRESENT CLINICAL TESTS FOR ALDOSTERONE, a-I
FETAL PROTEIN (CANCER OF THE LIVER), RHUMATOID ARTHRITIS
(NOW PERFORMED BY LATEX FIXATION TEST).
DISCONTINUE: PURIFICATION OF MACROMOLECULES IN SPACE DOES NOT APPEAR
PROMISING.
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PURIFICATION OF B- HYDROXYBUTYRATE DEHYDROGENASE
PURPOSE: OBTAIN FOR MORE PRECISE DETERMINATION OF THE IMPORTANT
KETONES, AS PRESENT TESTS ARE MORE SEMIQUANTITATIVE THAN
PRECISE.
DISCONTINUE: SPACE PROCESSING NOT ADVANTAGEOUS FOR MACROMOLECULAR
PURl FI CATION.
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BONE MARROW CELLULAR SEPARATION FOR TRANSFUSION PURPOSES
DISCONTINUE: EARTH LEUKOPACK® EXTRACTION BETTER AND SIMPLIER FOR MOST
TRANSFUSION PURPOSES. NOT ENOUGH VOLUME POSSIBLE IN SPACE.
SEPARATION OF BONE MARROW STEM (PRIMORDIAL) CELLS IN SPACE
THUS OF ONLY ACADEMIC INTEREST.
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B. EXPERIMENTS
44urLittlenc Arthur D Littlk Inc
TEST PROGRAMMED CELL DEATH THEORY VS. IMMORTAL CELL LINE
PURPOSE: IT HAS BEEN CLAIMED THAT NORMAL CELLS DIFFER FROM CANCER
CELLS IN THAT NORMAL CELLS LIVE FOR A PREESTABLISHED NUM-
BER OF GENERATIONS (HAYFLICK) WHEREAS CANCER CELLS ARE
IMMORTAL AND KEEP ON DIVIDING FOREVER. THESE EXPERIMENTS
HAVE BEEN PERFORMED IN TISSUE CULTURE ON EARTH WHERE CELLS
TOUCH EACH OTHER AND THE GLASS CONTAINER OR PETRIDISH.
THUS, IT IS NOT CLEAR WHETHER THERE IS A PREDETERMINED RULE
ON PROGRAMMED CELL DEATH OR WHETHER CONTACT INHIBITION
AND THE RATE AT WHICH NUTRIENTS CAN BE PROVIDED LIMIT THE
NUMBER OF DIVISIONS. IN A GRAVITY SYSTEM IN WHICH
CELLS ARE IN SUSPENSION IT WOULD BE POSSIBLE TO TEST THIS
THEORY.
BACKGROUND: DR. L. GLICK, PRESIDENT OF ASSOCIATE BIOMEDIC SYSTEMS,
HAS PROPOSED THIS EXPERIMENT.
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PURIFICATION AND PROPERTIES OF MULTIPLE FORMS OF BRAIN ACETHYCHOLINESTERASE
DESCRIPTION: BRAIN TISSUE CAN BE HOMOGENIZED, THEN PASSED THROUGH FILTERS
OF VARYING SIZES TO OBTAIN HOMOGENEOUS MEMBRANE FRACTIONS.
THE MEMBRANES COULD BE SEPARATED BY ELECTROPHORESIS IN
SPACE AND AFTER ASSAYING FRACTIONS CONTAINING ACETHY-
CHOLINESTERASE (OR OTHER INTERESTING MATERIAL) CORRELATED
WITH STRUCTURE AND FUNCTION OF THE TISSUE.
PURPOSE: OBTAIN NERVE MEMBRANE FRACTIONS CONTAINING ACETHLCHOLIN-
ESTERASE (OR OTHER MARKERS OR SUBSTANCES OF INTEREST).
ADVANTAGES WITH PRESENT TECHNIQUES MEMBRANES HAVE TO BE SOLUBILIZED
OF SPACE: AND ARTIFACTS ARE INTRODUCED, EXPERIMENT DISCUSSED WITH
DR. JOHN T. DULANEY, DEPARTMENT OF MOLECULAR BIOLOGY,
VANDERBI LT UNIVERSITY.
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STUDY MOBILITIES OF VARIOUS ARTIFICIAL CELL MOSAICS
DESCRIPTION: VARIOUS COMPOUNDS TO WHICH CELLULAR CHARGES ARE USUALLY
ASCRIBED (SUCH AS NANA, -SH GROUPS, ETC.) ARE ABSORBED
ONTO QUARTZ PARTICLES AND THE RESULTANT ARTIFICIAL CELLS
SUBJECTED TO ELECTROPHORESIS.
PURPOSE: DETERMINE EFFECTS OF VARIOUS CHARGED GROUPS ON OVERALL
MOBILITY. ALTHOUGH KNOWLEDGE OF THE CELL SURFACE ARCHI-
TECTURE IS EXTREMELY IMPORTANT AND MEASUREMENT OF CELL
MOBILITIES ON EARTH IS UTILIZED TO INFER THE TYPES OF
CHARGES PRESENT ON THE CELL SURFACE, THERE IS NO RELIABLE
WAY OF CONVERTING MOBILITIES INTO COMPOUNDS, AS ALL METHODS
ARE INDIRECT (ENZYMATIC TREATMENT OF THE SURFACE) AND NO
GOOD MODELS ARE AVAILABLE. SPACE ELECTROPHORESIS OF MODEL
SYSTEMS WOULD PROVIDE USEFUL INFORMATION OF THIS TYPE:
MODEL CELLS CAN BE ELECTROPHORESED FOR LONG PERIODS OF TIME.
MEASUREMENT: LABEL DIFFERENT "CELLS" WITH VARIOUS STAINS, OR FLUORESCENT
LABELS, TAKE PICTURES, NOT NECESSARY TO RETURN SYSTEM TO
EARTH. NO PROBLEMS OF KEEPING LIVE BIOLOGICAL MATERIAL,
BUT INFORMATION EXTREMELY VALUABLE.
BACKGROUND: SIMILAR EXPERIMENTS DONE WITH LONG CHAIN FATTY ACIDS, ALCO-
HOLS, AMINES, ETC. BY KRUYT AND WENT, 1931; GROWNEY, 1941;
BANGHAM ET AL. 1958. TYPICAL MOSAIC DATA INFERED FOR CELLS
GIVEN IN TABLES 9, 10, AND II (MEHRISHI, PROGRESS IN BIO-
PHYSICS AND MOLECULAR BIOLOGY, 1973)
PROBLEMS: NONE FORESEEN, DEFINITE ADVANTAGES OVER EARTH.
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TABLE 9
CELL SURFACE MOLECULAR MOSAIC
GROUPS/CHARGES ON THE SURFACE OF HUMAN THROMBOCYTES
REPRO"UCI JT1TY OF THE
ORIGINALI PAGi Ib P U R
Average distance
Area per between
Groups or Number per cell group/charge neighbouring groups
charges (x 105) (A2 x 103) (A)
1. Positively
charged AMINO 2.42 11.7 108
2. Phosphate 5 .0b 5.7 75(alkaline
phosphatas:-
susceptible)
3. -SH groups 2.75 10.3 32
4. a-Carboxyl 9.5 2.98 55
(neuraminidase-
susceptible-
N-acetylncura- 8.9 3.2 56
rninic acid)
5. Unidentified 6.53
anionogcnic
6. Total electron 20.42
charges
7. Net electron 18.0
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TABLE 10
CELL SURFACE MOLECULAR MOSAIC
GROUPS/CHARGES ON THE SURFACE OF HUMAN LYMPHOCYTE
Average distance
betweenbct w 'cn
Groups Area per ncighbuuring
or Number perCcll grouplcharge groups
charges (x 10s) (A 2) (A)
1. Total electron
charges 102.9
2. Electron charges
contributing to
the electrokinetic
charge 93.4
3. a-Carboxyl
(neuraminidase-
susceptible- 29.2 3880 62
N-acetyl-
neuraminic acid)
4. Phosphate (RNase-
susceptible) 8.7 13000 114
5. Positively
charged amino 9.5 11900 109
6. Unidentified
anionogenic 55.5 2050 45
7. -SH groups 19.8 5760 76
49
Arthur D Little Inc
TABLE 11
CELL SURFACE MOLECULAR MOSAIC
GROUPS/CHARGES ON THE SURFACE OF EHRLICH ASCITES TUMOUR CELLS
Average distance
between
Groups Area per neighbouring
or Number per cell group charge groups
charges (x 107) (A2) (A)
1. Total electron 8
charges
2. Electroncharges 6.88
contributing to the
electrokinetic charge
3. a-Carboxyl
(neuraminidase- 2.35 3830 61.9
susceptible-
N-acetyl-
neuraminic acid)
4. Phosphate (RNase- 1.19 7550 86.9
susceptible)
5. Positively charged 1.17 7700 87.6
amino
6. Unidentified 3.91 2300 48
anionogenic
7. -SH groups 3.69 2440 49.4
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EFFECTS OF CHEMOTHERAPEUTIC AGENTS ON MOBILITIES OF NORMAL AND CANCER CELLS
DESCRIPTION: CHEMOTHERAPEUTIC AGENTS ADDED IN SMALL DOSAGES TO BOTH NORMAL
AND CANCER CELLS OF VARIOUS TYPES TO STUDY SLIGHT CHANGES
IN MOBILITY AND MOBILITY VARIATIONS WITH INCREMENTAL CHANGES
IN DOSAGE.
PURPOSE: IT IS IMPORTANT TO FIND SIMPLE IN VITRO TECHNIQUES FOR
SCREENING CHEMOTHERAPEUTIC AGENTS.
ADVANTAGE OF VERY SMALL CHANGES IN MOBILITY COULD BE OBSERVED. AS THE
SPACE: SCREENING PROCESS IS EXTREMELY EXPENSIVE ON EARTH ANY PRO-
MISING TECHNIQUE FOR REDUCING THE SCREENING TIME SHOULD BE
INVESTIGATED AND THE SPACE PROGRAM WOULD BE COMPETITIVE
EVEN AT THE COST LEVEL.
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CORRELATIONS BETWEEN CHANGES IN SURFACE CHARGE
DENSITY AND CELL CONTACT BEHAVIOUR
DESCRIPTION: STUDY CHANGES IN MOBILITIES IN RESPONSE TO CONTACT BEHAVIOUR
DISCONTINUE: LACK OF CORRELATION BETWEEN CHARGE AND CONTACT BEHAVIOUR
IN EXPERIMENTS PERFORMED ON DISSOCIATED CHICK EMBRYO CELLS
ON EARTH (KEMP, 475; JOHNES, 476)*
* NUMBERS REFER TO THE MEDLINE REFERENCES IN OUR STUDY,
SEE APPENDIX 3.
52
Arthur D Little Inc
PREORDAINED FUNCTION IN EMBRYOGENESIS
DESCRIPTION: DEAGGREGATE CELLS IN A GIVEN EARLY EMBRYONIC STAGE AND
MEASURE RESULTANT MOBILITIES.
PURPOSE: STUDY MOBILITIES OF CELLS AT VARIOUS STAGES OF EMBRYOGENESIS
TO DETERMINE, THROUGH THESE DIFFERENCES, IF CELLS WHICH
LOOK MORPHOLOGICALLY THE SAME MAY HAVE A PREORDAINED FUNCTION,
AS JUDGED THROUGH DIFFERENCES IN MOBILITY.
BACKGROUND: STUDIES ON PRESUMPTIVE EPIDERMIS OF THE FROG SHOWS THAT
CELLS WHICH ARE DEVELOPMENT ALLY AHEAD OF OTHERS SHOW DIFF-
ERENT ELECTROPHORETIC MOBILITY. DASQUPTA, KUNG HO (336).
ADVANTAGE OF IN ADDITION TO THE USUAL CELL ELECTROPHORESIS PROBLEMS, IT
SPACE: WOULD BE POSSIBLE TO DETECT SMALLER DIFFERENCES IN MOBILITIES,
HENCE DETECT PREORDAINED FUNCTION AT EARLIER STAGES (THE
TWO CELL LEVEL) IF IT EXISTS.
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SEPARATION OF BONE MARROW CELLS TO STUDY HEMOPOIESIS
DESCRIPTION: MORPHOLOGICALLY SIMILAR BONE MARROW CELLS ARE SEPARATED
BY ELECTROPHORESIS AND CULTURED. CULTURES RECOVERED AND
STUDIED TO OBTAIN PURE GRANULOCYTE CELL LINES.
PURPOSE: EXTREMELY IMPORTANT IN THE DETERMINATION OF THE CAUSE
OF LEUKEMIA TO OBTAIN PURE GRANULOCYTE LINES, THIS HAS
NOT BEEN ACHIEVED BY ANY TECHNIQUE SO FAR.
ADVANTAGES DETECTION OF VERY SMALL CHARGE DIFFERENCES IN CELLS
OF SPACE: WHICH ARE MORPHOLOGICALLY AND FUNCTIONALLY VERY CLOSE TO
EACH OTHER.
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STUDY MARKERS OF TUMOR GROWTH
DESCRIPTION: SUSPEND CELLS AT THEIR ISOELECTRIC POINT AND ALLOW SMALL
MOLECULES TO MOVE IN THE ELECTROPHORETIC FIELD. AFTER A
FEW HOURS, EXTRACT SAMPLES FROM VARIOUS PARTS OF THE
ELECTROPHORESIS TUBE AND SEND SAMPLES OF THE SMALL MOLECULES
TO EARTH.
PURPOSE: IT MAY BE USEFUL TO KNOW WHAT SUBSTANCES (MOSTLY SMALL
MOLECULES) ARE PRODUCED UNIQUELY BY TUMOR CELLS.
DISCONTINUE: MAMMALIAN CELLS DO NOT SURVIVE AT THEIR ISOELECTRIC POINT.
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SEPARATION OF X AND Y OR SPERM CARRYING DIFFERENT GENES
PURPOSE: OBTAIN SPERM CARRYING X OR Y CHROMOSOMES ONLY, OR SPERM
CARRYING SPECIFIC GENETIC MUTATION.
DISCONTINUE: BACKGROUND ON EARTH SHOWS THAT ELECTROPHORESIS DOES NOT
EFFECT THE SEPARATION. THE EARTH TECHNIQUE TO SEPARATE
X AND Y SPERM (DR. R. J. ERICKSON) IS BASED ON DIFFERENTIAL
MOTILITY OF SPERM IN TWO MEDIA OF DIFFERENT VISCOSITY:
SPERM REQUIRE GRAVITY FOR ORIENTATION.
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STUDY PLATELET - MATERIAL INTERACTION
DESCRIPTION: A DISPERSION OF A SAMPLE MATERIAL IS INTRODUCED IN THE
ELECTROPHORESIS CELL IS SPACE, THE PARTICLES FLOAT RATHER
THAN SEDIMENT. PLATELETS CAN BE RUN THROUGH THE MATERIAL
SUSPENSION DRIVEN BY THE ELECTROPHORETIC FIELD AND THE
NEGATIVE CHARGE ON THE PLATELET. THE INTERACTION OF THE
MATERtAL WtTH THE PLATELFT WILL DETEDMINE MIGRATMON RATE.
PURPOSE: STUDY THE BEHAVIOUR OF MATERIALS UTILIZED IN THE ARTIFICIAL
HEART PROGRAM, THE NATIONAL HEART AND LUNG INSTITUTE IS
CURRENTLY INTERESTED IN ANALYSING INTERACTIONS OF MATERIALS
AND BLOOD COMPONENTS.
ADVANTAGES EQUIVALENT EXPERIMENT IMPOSSIBLE TO PERFORM ON EARTH.
OF SPACE:
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ANALYSIS OF NON-HISTONE NUCLEAR PROTEINS
PURPOSE: ISOLATE PROTEINS INVOLVED IN CONTROL OF GENETIC EXPRESSION.
THESE ARE INSOLUBLE COMPLEXES THAT ARE HARD TO ANALYZE AND
CANNOT BE SEPARATED ON POLYACRYLANIDE GEL OR BY ISOELECTRIC
FOCUSING BECAUSE MATERIALS ARE INSOLUBLE AT THEIR ISOLELEC-
TRIC POINT.
ADVANTAGES PRECIPITATION WOULD NOT OCCUR.
OF SPACE:
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ISOLATE CELLS IN THE Go STAGE OF THE CELL CYCLE
DESCRIPTION: CELLS ARE SUBJECTED TO ELECTROPHORESIS AS THEY GO THROUGH
MITOSIS IN THE PRESENCE OF VARIOUS DRUGS. THE SPECIFIC
CELLS WHICH DO NOT DIVIDE (CHARGE REMAINS CONSTANT) WILL
BE RECOVERED.
PURPOSE: TO UNDERSTAND THE EFFECTS OF DRUGS WHICH SEND CELLS TO
THE Go (RESTING) STAGE. THIS HAS IMPORTANCE IN THE TREAT-
MENT OF CANCER.
ADVANTAGES THERE ARE NO OBVIOUS MORPHOLOGICAL DIFFERENCES BETWEEN
OF SPACE: CELLS IN Go AND G I, HOWEVER, SMALL DIFFERENCES IN CHARGE
ARE TO BE EXPECTED.
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ISOLATION OF MICROTUBULES OF MITOTIC SPINDLE
PURPOSE: UNDERSTAND STRUCTURE AND FUNCTION OF SPINDLE DURING MITOSIS,
SEVERAL GROUPS THROUGHOUT THE UNITED STATES ARE WORKING ON
TH I S.
PROCEDURE: LYSE CELLS IN VARIOUS STAGES OF MITOSIS, PERFORM ELECTROPHORESIS
IN SPACE TO OBTAIN PURE FRACTIONS.
ADVANTAGES: AS IN THE CASE OF CHROMOSOMES, IT IS DIFFICULT TO OBTAIN
PURE INSOLUBLE FRACTIONS.
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EFFECTS OF SPACE RADIATION ON CELL MOBILITY
DESCRIPTION: A SHIELDED AND AN UNSHIELDED SET-UP IN WHICH CELLS ARE
SUBJECTED TO AN ELECTRIC FIELD WILL BE COMPARED FOR
CELLULAR MOBILITY.
PURPOSE: TO STUDY POSSIBLE SUBTLE ORBITAL RADIATION EFFECTS.
BACKGROUND: IT IS KNOWN THAT RADIATION HAS EFFECTS ON ELECTROPHORETIC
CELL MOBILITIES (MERISHI).
ADVANTAGES IN THIS PARTICULAR APPLICATION "SPACE" PROVIDES THE RADIA-
OF SPACE: TION DOSAGE ALLOWING A CHECK ON THE EFFECTS OF SPACE
TRAVEL ON CELLS SUCH AS BLOOD CELLS.
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CULTURING OF MAMMALIAN CELLS WHICH WILL NOT GROW IN CULTURE
(NOT INVOLVING ELECTROPHORESIS)
PURPOSE: GROW IN LARGE QUANTITIES CELLS WHICH ARE REQUIRED FOR
RESEARCH PURPOSES AND CANNOT GROW IN SUSPENSION ON EARTH
AT Ig WHICH DISRUPTS MANY CELLS, AS THE CELLS MUST BE
ARTIFICIALLY SUSPENDED BY AGITATION OF THE MEDIUM.
ADVANTAGE: NO SEDIMENTATION IN SPACE.
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ISOLATED HUMAN CHROMOSOME FRACTIONS FOR MOLECULAR BIOLOGY STUDIES
PURPOSE: ISOLATE FRACTIONS CONTAINING A FEW GENES, WHICH CAN THEN
BE USED FOR CORRELATING STRUCTURE AND FUNCTION.
ADVANTAGES CHROMOSOME FRACTIONS GIVE INSOLUBLE, TANGLED COMPLEXES
OF SPACE: UTILIZING CENTRIFUGATION ON EARTH.
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OBSERVE MOBILITY CHANGES IN RESPONSE TO ONCOGENIC AND OTHER VIRUSES
PURPOSE: STUDY ELECTROPHORETIC MOBILITY OF CELLS IN RESPONSE TO
CANCER AND OTHER DISEASE PRODUCING VIRUSES TO ANALYZE CHANGES
IN MEMBRANE STRUCTURE.
BACKGROUND: THE ELECTROPHORETIC MOBILITY OF INTESTINAL EPITHELIAL
CELLS WAS MEASURED IN THE PRESENCE AND ABSENCE OF CHOLERA
ORGANISMS AND DIFFERENCES IN MOBILITY WERE OBSERVED, EVEN
THOUGH STRUCTURALLY THE TWO TYPES OF CELL LOOKED THE SAME.
THIS INDICATES THE APPROACH MIGHT SERVE AS A GOOD TEST FOR
DETECTING SMALL CELLULAR CHANGES WHICH FOLLOW INFECTION.
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